Optic nerve involvement is common among patients presenting with CIS of MS. Adding the optic nerve as a fifth site for dissemination in space fulfillment increases the sensitivity, decreases the ...

A multicenter, double-blind, placebo-controlled study conducted over 2 years enrolled 303 patients ages 18 to 55 years with recent CIS suggestive of MS. Disease activity was observed in a smaller ...

January 30, 2010 — Tears may one day replace cerebrospinal fluid in diagnosing multiple sclerosis, report researchers. The new isoelectric focusing technique detects oligoclonal bands in eye fluid and ...

Teriflunomide treatment incurred an unadjusted risk reduction of 63% and an adjusted risk reduction of 72% in inhibiting a first clinical demyelinating event in patients with multiple sclerosis (MS).

Radiologically isolated syndrome (RIS) involves MS-like lesions on MRI without clinical symptoms, with a significant risk of progression to MS. Updated 2023 RIS criteria improve diagnostic accuracy, ...

WEST PALM BEACH, FL – The presence of paramagnetic rim lesions (PRLs) on MRI may help in the diagnosis of multiple sclerosis (MS), as well as in predicting more severe disease course, new research ...

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...

Mayzent (siponimod) is a prescription drug that’s used to treat clinically isolated syndrome and certain types of multiple sclerosis (MS). Mayzent can cause side effects that range from mild to ...